GGrantIndex
Sort

39,280 grants matching leukemia

Molecular mechanisms underlying clonal expansion of hematopoietic stem cells

$393,750
Yan Liu · Indiana University Indianapolis · R01 · FY2019 · HL

Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma

$393,718
Michael D Hogarty · Children'S Hosp Of Philadelphia · R01 · FY2022 · CA

Validating the eCyPA/CD147 signaling complex for myeloma therapy

$393,715
Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2015 · CA

A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients

$393,591
Manuel B Datiles · National Eye Institute · ZIA · FY2016 · EY

A chicken model to study hepatitis E virus pathogenesis

$393,587
Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2016 · AI

Function of AML-1/Runx1 in Early Hematopoiesis

$393,559
Mount Sinai School Of Medicine Of Nyu · R01 · FY2005 · DK

Function of AML-1/Runx1 in Early Hematopoiesis

$393,559
Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · DK

Function of AML-1/Runx1 in Early Hematopoiesis

$393,559
Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · DK

The Contribution ofInfection to Preleukemic Clonal Hematopoiesis

$393,558
Katherine Yudeh King · Baylor College Of Medicine · R01 · FY2017 · HL

Functions of JARID2 in Normal and Neoplastic Hematopoiesis

$393,541
Grant Anthony Challen · Washington University · R01 · FY2020 · HL

An evolutionary framework to elucidate and interpret the genetic architecture of complex traits in diverse populations

$393,531
Charleston Chiang · University Of Southern California · R35 · FY2021 · GM

The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma

$393,530
Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma

$393,530
Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

Biochemistry of Eukaryotic Messenger RNA Synthesis

$393,525
Ronald C. Conaway · Stowers Institute For Medical Research · R01 · FY2010 · GM

TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM

$393,518
Chih-Chi Andrew Hu · Wistar Institute · R01 · FY2015 · CA

Hematopoietic Stem Cell Transplant for Immunodeficiency with MDS

$393,515
Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Tumor Selective Apoptosis by TRAIL

$393,508
Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL

Tumor Selective Apoptosis by TRAIL

$393,508
Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2007 · HL

Tumor Selective Apoptosis by TRAIL

$393,508
Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL

Fate of Spermatogonial Stem Cells

$393,506
Georgetown University · R01 · FY2003 · HD

Project 1: Isolation Chemistry of Plants and U.S. Lichens and Biological Evaluation

$393,454
Alan Douglas Kinghorn · Ohio State University · P01 · FY2025 · CA

The role of Kmt2c/MLL3 in hematopoietic stem cell self-renewal, commitment and exhaustion

$393,438
Jeffrey Alan Magee · Washington University · R01 · FY2020 · HL

Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells

$393,420
Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA

Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells

$393,420
Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA

Molecular dissection of Hematopoietic Stem Cell specification triggered by inflammatory mediators

$393,399
Raquel Espãn Palazã“n · Iowa State University · R01 · FY2022 · DK